1. The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
    Magdalena Paolino et al, 2016, Cancers CrossRef
  2. Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP-9
    Xin-Jun Chen et al, 2016 CrossRef
  3. miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3
    Shu Liu et al, 2016 CrossRef
  4. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
    Guangming Zhao et al, 2017 CrossRef
  5. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
    Chanitra Thuwajit et al, 2017, Med Res Rev CrossRef
  6. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan et al, 2017, Cell Biosci CrossRef
  7. Plant Flavone Apigenin: an Emerging Anticancer Agent
    Eswar Shankar et al, 2017, Curr Pharmacol Rep CrossRef
  8. Apigenin: A dietary flavonoid with diverse anticancer properties
    Josip Madunić et al, 2018, Cancer Letters CrossRef
  9. Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
    Daniel E Johnson et al, 2018, Nat Rev Clin Oncol CrossRef
  10. Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
    Shunyu Hou et al, 2018, PLoS ONE CrossRef
  11. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus
    Katie O’ Sullivan et al, 2018, IJMS CrossRef
  12. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function
    Dharambir Kashyap et al, 2018, Journal of Functional Foods CrossRef
  13. null
    Elizabeth Cedars et al, 2018 CrossRef
  14. Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor
    Benjamin M. Hariri et al, 2017, J. Biol. Chem. CrossRef
  15. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
    Sherri Smart et al, 2018, Cancers CrossRef
  16. Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB
    Suat Erdogan et al, 2019, Invest New Drugs CrossRef
  17. α-Mangostin and Apigenin Induced Cell Cycle Arrest and Programmed Cell Death in SKOV-3 Ovarian Cancer Cells
    Teeranai Ittiudomrak et al, 2019, ToxicolRes CrossRef
  18. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
    Shulin Xiang et al, 2019, J Pineal Res CrossRef
  19. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
    Qingmei Ye et al, 2019, Front. Oncol. CrossRef
  20. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL
    Rui Li et al, 2015, Tumor Biol. CrossRef
  21. null
    Derek W. Edwardson et al, 2019 CrossRef
  22. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells
    Yefang Xu et al, 2015, Int J Gynecol Cancer CrossRef
  23. Novel Recombinant Protein FlaA N/C Protects against Radiation Injury via NF-κB Signaling
    Ying Xu et al, 2015, Radiation Research CrossRef
  24. Gene of the month:Axl
    Matthew Brown et al, 2016, J Clin Pathol CrossRef
  25. Metabolic Variations of Flavonoids in Leaves of T. media and T. mairei Obtained by UPLC-ESI-MS/MS
    Tao Wang et al, 2019, Molecules CrossRef
  26. Health functionality of apigenin: A review
    Fahad Ali et al, 2017, International Journal of Food Properties CrossRef
  27. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma
    Saeideh Momtaz et al, 2017, BioFactors CrossRef
  28. Apigenin: A current review on its beneficial biological activities
    Xiang Zhou et al, 2017, J Food Biochem CrossRef
  29. The potential and controversy of targeting STAT family members in cancer.
    Yannick Verhoeven et al, 2020, Semin Cancer Biol CrossRef
  30. Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
    Joo Hyun Kim et al, 2019, BMC Cancer CrossRef
  31. Novel activators and small-molecule inhibitors of STAT3 in cancer
    Lehe Yang et al, 2019, Cytokine & Growth Factor Reviews CrossRef
  32. Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks
    Deepti Singh et al, 2020, PRA CrossRef
  33. null
    Nellie K. McDaniel et al, 2020 CrossRef
  34. Investigation Of Possible Effects Of Apigenin, Sorafenib and Combined Applications On Apoptosis And Cell Cycle In Hepatocellular Cancer Cells
    Nazlı Şirin et al, 2020, Gene CrossRef
  35. Apigenin as an anticancer agent.
    Muhammad Imran et al, 2020, Phytother Res CrossRef
  36. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
    Xiaolan Zhu et al, 2017, Oncotarget CrossRef
  37. Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
    Zhiqiang Guo et al, 2017, Oncotarget CrossRef
  38. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
    Doo-Sik Kong et al, 2016, Oncotarget CrossRef
  39. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
    Xiaofeng Zhao et al, 2017, Oncotarget CrossRef
  40. A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer
    Chih-Ming Su et al, 2016, Oncotarget CrossRef
  41. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
  42. Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells
    Wei-Chien Huang et al, 2016, Oncotarget CrossRef
  43. Immunotherapies in ovarian cancer
    Elena García-Martínez et al, 2020, European Journal of Cancer Supplements CrossRef
  44. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways
    Mei Tang et al, 2020, World J Tradit Chin Med CrossRef
  45. Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
    Min Tian et al, 2021, Acta Pharmacol Sin CrossRef
  46. Phytoestrogens for Cancer Prevention and Treatment
    Margalida Torrens-Mas et al, 2020, Biology CrossRef
  47. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
    Guangxing Li et al, 2020, Molecules CrossRef
  48. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
    Susan R. Mallery et al, 2017, Cancer Prev Res CrossRef
  49. Polyphenolic molecules targeting signal transducer and activator of transcription 3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
  50. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Luciana Mosca et al, 2021, Drug Resistance Updates CrossRef
  51. Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway
    Hyo In Kim et al, 2021, Am. J. Chin. Med. CrossRef
  52. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
  53. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
    Tatyana Novoyatleva et al, 2021, Commun Biol CrossRef
  54. The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
    Szulc-Kielbik Izabela et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  55. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  56. null
    Alexander V. Sirotkin et al, 2022 CrossRef
  57. Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
    Ya-Hui Chen et al, 2022, Cancers (Basel) CrossRef
  58. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)
    Ranzhiqiang Yang et al, 2022, Mol Med Rep CrossRef
  59. Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model
    Gamze Tanriover et al, 2022, ACAMC CrossRef
  60. Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
    Dingchang Li et al, 2022, Front. Genet. CrossRef
  61. Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
    Aimee Rendell et al, 2022, Biomedicines CrossRef
  62. Modern aspects of the use of natural polyphenols in tumor prevention and therapy
    Galina Sufianova et al, 2022, Front. Cell Dev. Biol. CrossRef
  63. The Potential Role of Apigenin in Cancer Prevention and Treatment
    Arshad Husain Rahmani et al, 2022, Molecules CrossRef
  64. Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment
    Qiao Yi Chen et al, 2022, Cancer Letters CrossRef
  65. A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
    Ahmad Nasimian et al, 2023, IJMS CrossRef
  66. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells
    Yu Wang et al, 2024, Journal of Ethnopharmacology CrossRef
  67. Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets
    Kaixi Ding et al, 2024, BMC Genomics CrossRef